Alkermes Gross Profit 2006-2019 | ALKS

Alkermes gross profit from 2006 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Alkermes Annual Gross Profit
(Millions of US $)
2019 $991
2018 $918
2017 $749
2016 $614
2015 $489
2014 $443
2013 $299
2013 $405
2012 $262
2011 $134
2010 $129
2009 $283
2008 $200
2007 $195
2006 $143
2005 $59
Alkermes Quarterly Gross Profit
(Millions of US $)
Q4 2019 $366
Q3 2019 $213
Q2 2019 $234
Q1 2019 $178
Q4 2018 $267
Q3 2018 $209
Q2 2018 $261
Q1 2018 $181
Q4 2017 $237
Q3 2017 $181
Q2 2017 $179
Q1 2017 $151
Q4 2016 $179
Q3 2016 $145
Q2 2016 $161
Q1 2016 $129
Q4 2015 $128
Q3 2015 $119
Q2 2015 $121
Q1 2015 $121
Q4 2014 $129
Q3 2014 $113
Q2 2014 $110
Q1 2014 $91
Q4 2013 $112
Q3 2013 $94
Q2 2013 $93
Q1 2013 $115
Q4 2012 $97
Q3 2012 $82
Q2 2012 $110
Q1 2012 $79
Q4 2011 $83
Q3 2011 $54
Q2 2011 $46
Q1 2011
Q4 2010 $31
Q3 2010 $35
Q2 2010 $30
Q1 2010
Q4 2009 $34
Q3 2009 $33
Q2 2009 $35
Q1 2009
Q4 2008 $150
Q3 2008 $35
Q2 2008 $66
Q1 2008
Q4 2007 $43
Q3 2007 $49
Q2 2007 $59
Q1 2007
Q4 2006 $49
Q3 2006 $49
Q2 2006 $42
Q1 2006
Q4 2005 $35
Q3 2005 $42
Q2 2005 $20
Q1 2005
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.804B $1.171B
Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.810B 15.07
CSL (CSLLY) Australia $100.765B 0.00
Gilead Sciences (GILD) United States $85.473B 11.00
Vertex Pharmaceuticals (VRTX) United States $63.215B 57.37
Biogen (BIIB) United States $57.963B 9.90
Regeneron Pharmaceuticals (REGN) United States $43.958B 18.62
Illumina (ILMN) United States $43.941B 45.43
Alexion Pharmaceuticals (ALXN) United States $22.707B 10.56
Seattle Genetics (SGEN) United States $20.339B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.638B 0.00
Incyte (INCY) United States $17.006B 36.49
BioMarin Pharmaceutical (BMRN) United States $15.988B 0.00
Genmab (GNMSF) Denmark $14.741B 65.11
Alnylam Pharmaceuticals (ALNY) United States $14.490B 0.00
Galapagos (GLPG) Belgium $14.198B 36.58
Exact Sciences (EXAS) United States $12.747B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.078B 56.43
BeiGene (BGNE) Cayman Islands $10.449B 0.00
Sarepta Therapeutics (SRPT) United States $9.349B 0.00
QIAGEN (QGEN) Netherlands $8.375B 25.79
Bio-Techne Corp (TECH) United States $7.997B 54.73
Guardant Health (GH) United States $7.916B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.099B 0.00
BioNTech SE (BNTX) Germany $6.958B 0.00
Reata Pharmaceuticals (RETA) United States $6.831B 0.00
Ascendis Pharma (ASND) Denmark $6.732B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.730B 17.11
Moderna (MRNA) United States $6.394B 0.00
Exelixis (EXEL) United States $6.311B 17.75
Amarin (AMRN) Ireland $6.294B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.105B 0.00
Repligen (RGEN) United States $5.517B 99.97
Acceleron Pharma (XLRN) United States $4.972B 0.00
Bluebird Bio (BLUE) United States $4.942B 0.00
China Biologic Products (CBPO) China $4.597B 25.89
Adaptive Biotechnologies (ADPT) United States $3.913B 0.00
MorphoSys AG (MOR) Germany $3.898B 0.00
Mirati Therapeutics (MRTX) United States $3.635B 0.00
Blueprint Medicines (BPMC) United States $3.619B 0.00
NeoGenomics (NEO) United States $3.569B 189.89
Immunomedics (IMMU) United States $3.550B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.532B 0.00
Zai Lab (ZLAB) China $3.517B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.395B 57.53
Emergent Biosolutions (EBS) United States $3.261B 32.40
MyoKardia (MYOK) United States $3.254B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.157B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.104B 0.00
Halozyme Therapeutics (HALO) United States $3.092B 0.00
Genmab (GMAB) Denmark $3.074B 6.33
Amicus Therapeutics (FOLD) United States $2.798B 0.00
UniQure (QURE) Netherlands $2.756B 0.00
Insmed (INSM) United States $2.737B 0.00
Arena Pharmaceuticals (ARNA) United States $2.706B 6.29
Denali Therapeutics (DNLI) United States $2.441B 0.00
Epizyme (EPZM) United States $2.209B 0.00
RA PHARMCTL INC (RARX) United States $2.201B 0.00
Fate Therapeutics (FATE) United States $2.183B 0.00
Principia Biopharma (PRNB) United States $2.120B 0.00
Alector (ALEC) United States $2.068B 0.00
REGENXBIO (RGNX) United States $1.980B 0.00
Zymeworks (ZYME) Canada $1.889B 0.00
Ligand Pharmaceuticals (LGND) United States $1.708B 49.86
Arvinas (ARVN) United States $1.698B 0.00
Akcea Therapeutics (AKCA) United States $1.686B 0.00
Zealand Pharma (ZEAL) Denmark $1.595B 0.00
Coherus BioSciences (CHRS) United States $1.525B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.465B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.456B 0.00
Myriad Genetics (MYGN) United States $1.448B 25.55
Editas Medicine (EDIT) United States $1.376B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Intra-Cellular Therapies (ITCI) United States $1.266B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.212B 0.00
Athenex (ATNX) United States $1.206B 0.00
PHARMA MAR SA (PHMMF) Spain $1.184B 0.00
Revance Therapeutics (RVNC) United States $1.143B 0.00
Twist Bioscience (TWST) United States $1.070B 0.00
Adverum Biotechnologies (ADVM) United States $1.020B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.014B 0.00
Mesoblast (MESO) Australia $0.948B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Sangamo Therapeutics (SGMO) United States $0.878B 0.00
Cytokineticsorporated (CYTK) United States $0.877B 0.00
DBV Technologies S.A (DBVT) France $0.861B 0.00
Vericel (VCEL) United States $0.852B 317.83
Codexis (CDXS) United States $0.821B 0.00
Heska (HSKA) United States $0.807B 206.14
ANI Pharmaceuticals (ANIP) United States $0.794B 13.54
Cellectis S.A (CLLS) France $0.742B 0.00
Retrophin (RTRX) United States $0.712B 0.00
Cara Therapeutics (CARA) United States $0.712B 0.00
Intrexon (PGEN) United States $0.695B 0.00
GENFIT S.A (GNFT) France $0.694B 0.00
Intellia Therapeutics (NTLA) United States $0.678B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.677B 5.70
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
NantKwest (NK) United States $0.620B 0.00
Anika Therapeutics (ANIK) United States $0.592B 19.20
UROGEN PHARMA (URGN) United States $0.586B 0.00
Kadmon Holdings (KDMN) United States $0.586B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.576B 0.00
AC Immune SA (ACIU) Switzerland $0.576B 13.31
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.552B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.538B 0.00
Prothena (PRTA) Ireland $0.521B 0.00
Clovis Oncology (CLVS) United States $0.517B 0.00
Arcus Biosciences (RCUS) United States $0.506B 0.00
Agenus (AGEN) United States $0.503B 0.00
Bellus Health (BLU) Canada $0.493B 0.00
Puma Biotechnology (PBYI) United States $0.477B 0.00
BioDelivery Sciences (BDSI) United States $0.472B 0.00
Compugen (CGEN) Israel $0.463B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Sorrento Therapeutics (SRNE) United States $0.456B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.449B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.437B 0.00
Merus (MRUS) Netherlands $0.436B 0.00
Dynavax Technologies (DVAX) United States $0.434B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.421B 0.00
Inovio Pharmaceuticals (INO) United States $0.421B 0.00
Precision BioSciences (DTIL) United States $0.420B 0.00
PDL BioPharma (PDLI) United States $0.419B 10.49
AnaptysBio (ANAB) United States $0.415B 0.00
Cue Biopharma (CUE) United States $0.399B 0.00
Avid Bioservices (CDMO) United States $0.383B 0.00
Mersana Therapeutics (MRSN) United States $0.373B 0.00
Kindred Biosciences (KIN) United States $0.369B 0.00
Stemline Therapeutics (STML) United States $0.345B 0.00
Gritstone Oncology (GRTS) United States $0.339B 0.00
Syros Pharmaceuticals (SYRS) United States $0.334B 0.00
Cellular Biomedicine (CBMG) United States $0.329B 0.00
CytomX Therapeutics (CTMX) United States $0.324B 0.00
Albireo Pharma (ALBO) United States $0.314B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.308B 2.13
AMAG Pharmaceuticals (AMAG) United States $0.302B 0.00
MannKind (MNKD) United States $0.301B 0.00
Starpharma Holdings (SPHRY) Australia $0.290B 0.00
Kamada (KMDA) Israel $0.290B 12.06
WAVE Life Sciences (WVE) Singapore $0.277B 0.00
IVERIC Bio (ISEE) United States $0.273B 0.00
VBI Vaccines (VBIV) United States $0.273B 0.00
Aduro Biotech (ADRO) United States $0.272B 0.00
POXEL SA FRANCE (PXXLF) France $0.271B 0.00
OSMOTICA PHARM (OSMT) United States $0.264B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.264B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.260B 0.00
Geron (GERN) United States $0.258B 0.00
Sutro Biopharma (STRO) United States $0.256B 0.00
Biofrontera AG (BFRA) Germany $0.253B 0.00
Novavax (NVAX) United States $0.247B 0.00
Seres Therapeutics (MCRB) United States $0.246B 0.00
ChromaDex (CDXC) United States $0.244B 0.00
Kala Pharmaceuticals (KALA) United States $0.239B 0.00
XOMA (XOMA) United States $0.238B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.236B 0.00
Protagonist Therapeutics (PTGX) United States $0.227B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.222B 0.00
Prometic Life Sciences (LMNL) Canada $0.221B 0.00
Theratechnologies (THTX) Canada $0.215B 0.00
Alcobra (ARCT) United States $0.210B 0.00
Fortress Biotech (FBIO) United States $0.210B 0.00
ADMA Biologics Inc (ADMA) United States $0.208B 0.00
Arbutus Biopharma (ABUS) Canada $0.208B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.205B 0.00
Exicure (XCUR) United States $0.205B 0.00
Cerecor (CERC) United States $0.201B 0.00
Athersys (ATHX) United States $0.194B 0.00
Affimed (AFMD) Germany $0.193B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.192B 0.00
TELA Bio (TELA) United States $0.180B 0.00
Strongbridge Biopharma (SBBP) United States $0.178B 4.77
Spero Therapeutics (SPRO) United States $0.172B 0.00
Windtree Therapeutics (WINT) United States $0.168B 0.00
Five Prime Therapeutics (FPRX) United States $0.165B 0.00
Abeona Therapeutics (ABEO) United States $0.162B 0.00
VTv Therapeutics (VTVT) United States $0.157B 0.00
Selecta Biosciences (SELB) United States $0.157B 0.00
Dyadic (DYAI) United States $0.154B 0.00
Aptinyx (APTX) United States $0.152B 0.00
Verastem (VSTM) United States $0.149B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
Liquidia Technologies (LQDA) United States $0.142B 0.00
PHASEBIO PHARMA (PHAS) United States $0.137B 0.00
ARAVIVE, INC (ARAV) United States $0.136B 0.00
Antibe Therapeutics (ATBPF) Canada $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.124B 0.00
Happiness Biotech Group (HAPP) China $0.119B 0.00
Arsanis (XFOR) United States $0.115B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.115B 0.00
Clearside Biomedical (CLSD) United States $0.112B 0.00
OvaScience (MLND) United States $0.107B 0.00
Enzo Biochem (ENZ) United States $0.106B 0.00
Prima BioMed (IMMP) Australia $0.104B 0.00
Northwest Biotherapeutics (NWBO) United States $0.103B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Applied Genetic Technologies (AGTC) United States $0.093B 0.00
Vaccinex (VCNX) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.091B 0.00
Emmaus Life Sciences (EMMA) United States $0.090B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.090B 0.00
Proteostasis Therapeutics (PTI) United States $0.087B 0.00
Acorda Therapeutics (ACOR) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
AIT Therapeutics (XAIR) United States $0.085B 0.00
Checkpoint Therapeutics (CKPT) United States $0.084B 0.00
Pluristem Therapeutics (PSTI) Israel $0.083B 0.00
Catalyst Biosciences (CBIO) United States $0.079B 0.00
Orgenesis (ORGS) United States $0.079B 5.08
Synlogic (SYBX) United States $0.078B 0.00
Trevena (TRVN) United States $0.072B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.067B 0.00
Advaxis (ADXS) United States $0.061B 0.00
China Health Industries Holdings (CHHE) China $0.058B 17.78
NewLink Genetics (NLNK) United States $0.058B 0.00
Soligenix (SNGX) United States $0.058B 0.00
DiaMedica Therapeutics (DMAC) United States $0.056B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
Idera Pharmaceuticals (IDRA) United States $0.046B 0.00
Organovo Holdings (ONVO) United States $0.043B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Evogene (EVGN) Israel $0.039B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.031B 0.00
Celsion (CLSN) United States $0.031B 0.00
Pulmatrix (PULM) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Stellar Biotechnologies (EDSA) Canada $0.029B 0.00
Oncobiologics (OTLK) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
VIVUS (VVUS) United States $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Unum Therapeutics (UMRX) United States $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.024B 0.00
Cleveland BioLabs (CBLI) United States $0.024B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
TOCAGEN INC (TOCA) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00